Visceral Adipose Tissue and Different Measures of Adiposity in Different Severities of Diffuse Idiopathic Skeletal Hyperostosis.
adiposity
diffuse idiopathic skeletal hyperostosis
intra-abdominal fat
risk factors
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
15 Jul 2021
15 Jul 2021
Historique:
received:
26
05
2021
revised:
28
06
2021
accepted:
13
07
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
7
8
2021
Statut:
epublish
Résumé
Diffuse idiopathic skeletal hyperostosis (DISH) is associated with both obesity and type 2 diabetes. Our objective was to investigate the relation between DISH and visceral adipose tissue (VAT) in particular, as this would support a causal role of insulin resistance and low grade inflammation in the development of DISH. In 4334 patients with manifest vascular disease, the relation between different adiposity measures and the presence of DISH was compared using DISH was present in 391 (9%) subjects. The presence of DISH was associated with markers of adiposity and had a strong relation with VAT in males (OR: 1.35; 95%CI: 1.20-1.54) and females (OR: 1.43; 95%CI: 1.06-1.93). In males with the most severe DISH (extensive ossification of seven or more vertebral bodies) the association between DISH and VAT was stronger (OR: 1.61; 95%CI: 1.31-1.98), while increased subcutaneous fat was negatively associated with DISH (OR: 0.65; 95%CI: 0.49-0.95). In females, increased subcutaneous fat was associated with the presence of DISH (OR: 1.43; 95%CI: 1.14-1.80). Markers of adiposity, including VAT, are strongly associated with the presence of DISH. Subcutaneous adipose tissue thickness was negatively associated with more severe cases of DISH in males, while in females, increased subcutaneous adipose tissue was associated with the presence of DISH.
Sections du résumé
BACKGROUND
BACKGROUND
Diffuse idiopathic skeletal hyperostosis (DISH) is associated with both obesity and type 2 diabetes. Our objective was to investigate the relation between DISH and visceral adipose tissue (VAT) in particular, as this would support a causal role of insulin resistance and low grade inflammation in the development of DISH.
METHODS
METHODS
In 4334 patients with manifest vascular disease, the relation between different adiposity measures and the presence of DISH was compared using
RESULTS
RESULTS
DISH was present in 391 (9%) subjects. The presence of DISH was associated with markers of adiposity and had a strong relation with VAT in males (OR: 1.35; 95%CI: 1.20-1.54) and females (OR: 1.43; 95%CI: 1.06-1.93). In males with the most severe DISH (extensive ossification of seven or more vertebral bodies) the association between DISH and VAT was stronger (OR: 1.61; 95%CI: 1.31-1.98), while increased subcutaneous fat was negatively associated with DISH (OR: 0.65; 95%CI: 0.49-0.95). In females, increased subcutaneous fat was associated with the presence of DISH (OR: 1.43; 95%CI: 1.14-1.80).
CONCLUSION
CONCLUSIONS
Markers of adiposity, including VAT, are strongly associated with the presence of DISH. Subcutaneous adipose tissue thickness was negatively associated with more severe cases of DISH in males, while in females, increased subcutaneous adipose tissue was associated with the presence of DISH.
Identifiants
pubmed: 34357130
pii: jpm11070663
doi: 10.3390/jpm11070663
pmc: PMC8305748
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Semin Arthritis Rheum. 2011 Oct;41(2):131-8
pubmed: 21377195
J Bone Miner Metab. 2015 Mar;33(2):221-9
pubmed: 24623190
Eur J Epidemiol. 1999 Oct;15(9):773-81
pubmed: 10608355
Rheumatology (Oxford). 2002 Jan;41(1):27-30
pubmed: 11792876
Radiology. 1976 Jun;119(3):559-68
pubmed: 935390
Scand J Rheumatol. 2017 Mar;46(2):156-158
pubmed: 27684733
Nutr Metab Cardiovasc Dis. 2007 May;17(4):319-26
pubmed: 17110092
Metabolism. 2015 Jan;64(1):105-13
pubmed: 25497343
Biochem Biophys Res Commun. 2000 Jan 27;267(3):752-5
pubmed: 10673363
Eur J Clin Nutr. 1988 Sep;42(9):805-15
pubmed: 3181112
Med Clin (Barc). 2017 Sep 8;149(5):196-202
pubmed: 28283270
Semin Arthritis Rheum. 2009 Apr;38(5):361-5
pubmed: 18304611
Nat Rev Rheumatol. 2013 Dec;9(12):741-50
pubmed: 24189840
Int J Obes Relat Metab Disord. 2001 Sep;25(9):1346-51
pubmed: 11571598
J Rheumatol. 1994 Sep;21(9):1725-30
pubmed: 7799357
Sci Rep. 2017 Sep 8;7(1):10955
pubmed: 28887474
J Rheumatol. 2010 Sep;37(9):1911-6
pubmed: 20551104
Adipocyte. 2012 Oct 1;1(4):192-199
pubmed: 23700533
Clin Radiol. 2018 Oct;73(10):910.e15-910.e20
pubmed: 30031587
Clin Rheumatol. 2018 Oct;37(10):2839-2845
pubmed: 30121711
Int J Obes Relat Metab Disord. 2004 Aug;28(8):1018-25
pubmed: 15197408
Arthritis Care Res (Hoboken). 2012 Nov;64(11):1765-9
pubmed: 22623449
Neurospine. 2021 Mar;18(1):109-116
pubmed: 33211945
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Curr Rheumatol Rep. 2021 Jan 26;23(1):6
pubmed: 33496875
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Br J Radiol. 2012 Jan;85(1009):1-10
pubmed: 21937614
Spine (Phila Pa 1976). 2016 Nov 1;41(21):1668-1676
pubmed: 27120057
J Am Geriatr Soc. 2017 Jul;65(7):1476-1481
pubmed: 28369706
J Clin Hypertens (Greenwich). 2007 Aug;9(8):622-8
pubmed: 17673884
J Gastroenterol Hepatol. 2008 Mar;23(3):411-7
pubmed: 17725596
Crit Pathw Cardiol. 2007 Jun;6(2):51-9
pubmed: 17667865